Crossmark

Myricetin attenuates experimental autoimmune prostatitis and inflammatory and oxidative injury in LPS-induced RWPE-1 cells potentially through modulation of MAPK/STAT3/NF-κB/Nrf2 signaling pathway

Crossref DOI link: https://doi.org/10.1186/s13062-026-00840-1

Published Online: 2026-05-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Hang

Zhang, Dahong

Zhang, Yanping

Han, Zhenwei

Teng, Zhihai

Wang, Yaxuan
Funding

Funding for this research was provided by:

Project of Medical Science Research in Hebei Province (20253077)
License Information

Text and Data Mining valid from 2026-05-23

Accepted Manuscript valid from 2026-05-23
More Information

Article History

Received: 24 April 2026

Accepted: 18 May 2026

First Online: 23 May 2026

Declarations

:

: The research was reviewed and approved by the Ethics Committee of the Second Hospital of Hebei Medical University (2024-AE244).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below